
|Articles|June 7, 2022
Daily Medication Pearl: Fosamprenavir Calcium (Lexiva)
Author(s)Saro Arakelians, PharmD
Fosamprenavir calcium (Lexiva ) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Advertisement
Medication Pearl of the Day: Fosamprenavir Calcium (Lexiva)
Indication: Fosamprenavir calcium (Lexiva) is an HIV protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Insight:
- Dosing:Therapy-naive adults, Lexiva 1400 mg twice daily; Lexiva 1400 mg once daily plus ritonavir 200 mg once daily.
- Dosage forms: 700 mg tablets and 50 mg/mL oral suspension.
- Adverse events:In adults, the most common adverse reactions (incidence ≥4%) are diarrhea, rash, nausea, vomiting, and headache.
- Mechanism of action: Fosamprenavir is an antiviral agent.
Source:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
3
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
4
Current and Emerging BCMAxCD3 Bispecifics
5